Fox Business - The Power to Prosper
Search Site

Biotechnology

Bernanke upbeat on innovation outlook in commencement address

Federal Reserve Chairman Ben Bernanke painted an upbeat picture on Saturday for the potential of innovation to lift living standards, delivering a sweeping look at the last 100 years that included memories of his 1963 South Carolina home.Bernanke made no reference to monetary policy or the immediate outlook for the U.S. economy in prepared remarks to graduates of Bard College at Simon's Rock, Massachusetts.But the die-hard baseball fan did manage to work in a reference to one of the sport's greats."Is it true, then, as baseball player Yogi Berra said, that the future ain't what it used to be?," the chairman said, noting the existence of serious skepticism that leaps in computers and other information technology would yield the same dramatic boost to growth and living standards as previous episodes of industrial revolution."Nobody really knows; as Berra also astutely observed, it's tough to make predictions, especially about the future. But there are some good arguments on the other sid...

Read More

  1. Supreme Court Sides With Monsanto on Patents

    The U.S. Supreme Court ruled Monday that Monsanto Co. (MON) can use its patents to prevent farmers from planting later generations of genetically engineered seeds wi...

  2. Supreme Court Rules for Monsanto in Patent Fight

     The U.S. Supreme Court ruled on Monday that an Indiana farmer violated giant agribusiness company Monsanto Co's patent for a type of soybean.In a case closely watch...

  3. MARKET SNAPSHOT: Stock Rally's Burden Shifts To The Consumer

    Consumer-related stocks, at the vanguard of this year's rally, may face particular headwinds this week as retailers report earnings and a slew of consumer data hits ...

  4. China Securities Regulator Sounds Warning With Ban of Ping An Securities

    China's securities regulator has banned Ping An Securities from underwriting new stock offers for three months following a finding of negligence.It is the first ban ...

  5. Monsanto, Dow Chemical Crops Face Further Delay

    The U.S. Department of Agriculture put the brakes on controversial new genetically modified corn, soybean and cotton seeds from Monsanto Co. (MON) and Dow Chemical C...

  6. Analysis: Drugmakers face more scrutiny of discordant U.S. prices

    The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end.Companies like Pfizer...

  7. S&P Highlights Biotech ETFs

    Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multipl...

  8. Amgen Forms China Joint Venture

    Amgen Inc. (AMGN) will form a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma Co. to bring its colon cancer drug Vectibix to the important Chines...

  9. Exelixis 1st-Quarter Loss Widened as Revenue Slumps Amid Year-Earlier Impacts

    Exelixis Inc.'s (EXEL) first-quarter loss widened as the biotechnology company's revenue declined mostly owing to $10.7 million in revenue recognized in the year-ear...

  10. Does a Rally Still Count if Led by Defensive Stocks?

    As Mike Ditka and just about any other Hall of Fame football coach will tell you, the best offense is often a good defense.Just don't try telling that to the bears, ...

  11. Valeant Posts 1st-Quarter Loss; Adjusted Earnings Beat

    Valeant Pharmaceuticals International Inc.'s (VRX) first-quarter loss widened, but excluding one-time items, results beat analyst expectations and the company hiked ...

  12. Wall Street Thrashed Amid Mounting Economic Worries

    FOX Business: Capitalism Lives HereDisappointing jobs data and swelling oil inventories ignited worries about the global economy, and sent stocks and energy futures ...

  1. Sanofi Could Exit Toulouse Site in 5 Years

    Sanofi SA (SAN.FR) will forge ahead with plans to restructure its French research and development operations, but will take five years to transform operations at its...

  2. ETFs to Watch May 17, 2013 (EEV, IAU, UUP)

    Here is the ETF Professor's ETF Watch List for Friday, May 17, 2013.Let's see if the First Trust NYSE Arca Biotech Index Fund (NYSE:FBT) can bounce back.Keep an eye ...

  3. U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

    Among the companies with shares expected to actively trade in Thursday's session are Cisco Systems Inc. (CSCO), Wal-Mart Stores Inc. (WMT) and Kohl's Corp. (KSS).Cis...

  4. FDA Approves J&J's Simponi for Ulcerative Colitis

    Johnson & Johnson's (JNJ) drug Simponi received U.S. Food and Drug Administration approval for patients with hard-to-treat cases of ulcerative colitis.The injectable...

  5. The No. 1 Reason Startups Fail

    Ask 10 entrepreneurs why startups fail and you'll get 10 different answers. But there's just one simple cause underlying all of them.

  6. Are You Funding Monsanto's Promotion of GMO Cops Overseas?

    U.S. taxpayers are footing the bill for overseas lobbying that promotes controversial biotech crops developed by U.S.-based Monsanto Co and other seed makers, a repo...

  7. ETFs to Watch May 14, 2013 (EWC, FBT, TUR)

    Here is the ETF Professor's ETF Watch List for Tuesday, May 14, 2013.The Market Vectors Gaming ETF (NYSE:BJK) continues to impress.Keep an eye on the iShares MSCI Ca...

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL